Premium
LONG‐TERM EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B‐CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION (ASCT)
Author(s) -
Ferreri A.J.,
Sassone M.C.,
Angelillo P.,
Zaja F.,
Re A.,
Spina M.,
Di Rocco A.,
Fabbri A.,
Stelitano C.,
Frezzato M.,
Rusconi C.,
Zambello R.,
Arcari A.,
Bertoldero G.,
De Lorenzo D.,
Volpetti S.,
Calimeri T.,
Perrone S.,
Cecchetti C.,
Ciceri F.,
Ponzoni M.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.65_2630
Subject(s) - medicine , lenalidomide , surgery , salvage therapy , autologous stem cell transplantation , clinical endpoint , median follow up , transplantation , oncology , clinical trial , chemotherapy , multiple myeloma